13 June 2012 14:04 [Source: ICIS news]
Butamax said that the
Citing the order, Butamax said that Gevo “shall not deliver, provide, distribute, ship, release, or transfer in any way bio-based isobutanol produced at Gevo's Luverne facility from recombinant yeast microorganisms to any third party for any use or purpose, except that it may sell its bio-based isobutanol produced at the Luverne facility to Sasol for chemical applications and the US Air Force for jet fuel testing applications”.
Butamax CEO Paul Beckwith said that the order “provides protection for markets of key interest to Butamax” in the patent dispute between the two firms.
A Gevo media official could not immediately be reached for comment.
Butamax is a joint venture between DuPont and BP.
Check out Doris de Guzman’s Green Chemicals Blog for views on sustainability issues
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections